tag:blogger.com,1999:blog-19960708586651835842026-05-20T13:10:17.820+02:00Esclerosis múltipleToni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.comBlogger1436125tag:blogger.com,1999:blog-1996070858665183584.post-21073374409422696642017-11-30T20:41:00.001+01:002017-11-30T20:41:38.067+01:00<img alt="Resultado de imagen de lazo amarillo" src="data:image/jpeg;base64,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" />Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-82475341690366182622017-10-21T14:25:00.001+02:002017-10-21T14:25:42.674+02:00<blockquote class="twitter-tweet" data-lang="es">
<div dir="ltr" lang="es">
Habrá que recuperar habilidades</div>
— Toni Feliu Espada (@tonifeliuespada) <a href="https://twitter.com/tonifeliuespada/status/921713651475763202?ref_src=twsrc%5Etfw">21 de octubre de 2017</a></blockquote>
<br />
<script async="" charset="utf-8" src="//platform.twitter.com/widgets.js"></script>Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-12566054794282801442017-05-20T09:21:00.000+02:002017-05-20T09:21:04.271+02:00Pasar verguenza<span style="font-size: large;">Cuando te hacen el seguimiento de Servicios Sociales o de Teleasistencia y preguntan: ¿Cuanto hace que no vienen o llaman sus familiares?</span>Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com2tag:blogger.com,1999:blog-1996070858665183584.post-88238964171107568702017-04-22T17:16:00.001+02:002017-04-22T17:16:34.899+02:00<blockquote class="twitter-tweet" data-lang="es">
<div dir="ltr" lang="es">
La FDA aprueba el primer medicamento para tratar la esclerosis múltiple progresiva primaria <a href="https://t.co/9YifJuCre8">https://t.co/9YifJuCre8</a> vía <a href="https://twitter.com/mgenomica">@mgenomica</a></div>
— Toni Feliu Espada (@tonifeliuespada) <a href="https://twitter.com/tonifeliuespada/status/855802003850702848">22 de abril de 2017</a></blockquote>
<br />
<script async="" charset="utf-8" src="//platform.twitter.com/widgets.js"></script>Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-19900774651428140722017-03-30T14:28:00.004+02:002017-03-30T14:28:49.136+02:00<div style="background-color: white; border: 0px; color: #323232; font-family: Arial, Helvetica, Garuda, sans-serif; font-stretch: inherit; font-variant-numeric: inherit; line-height: inherit; margin-bottom: 20px; padding: 0px; text-align: justify; vertical-align: baseline;">
<div style="border: 0px; font-stretch: inherit; font-variant-numeric: inherit; line-height: inherit; margin-bottom: 20px; padding: 0px; vertical-align: baseline;">
<div style="border: 0px; font-stretch: inherit; font-variant-numeric: inherit; line-height: inherit; margin-bottom: 20px; padding: 0px; vertical-align: baseline;">
<span style="font-size: large;">La Administración de Alimentos y Medicamentos de EEUU (FDA, por sus siglas en inglés) <strong style="border: 0px; font-family: inherit; font-stretch: inherit; font-style: inherit; font-variant: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;">ha aprobado el ocrelizumab como tratamiento tanto para la EM recurrente como para la primaria progresiva</strong>, convirtiéndose por tanto en el primer tratamiento autorizado para pacientes de EM primaria progresiva.</span></div>
<div style="border: 0px; font-stretch: inherit; font-variant-numeric: inherit; line-height: inherit; margin-bottom: 20px; padding: 0px; vertical-align: baseline;">
<span style="font-size: large;">En los últimos resultados de sus ensayos, los investigadores encontraron que el ocrelizumab reducía las recaídas, la actividad por IRM y disminuía la progresión en EM remitente-recurrente. Además se encontró que <strong style="border: 0px; font-family: inherit; font-stretch: inherit; font-style: inherit; font-variant: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;">ralentizaba la progresión de la EM primaria progresiva</strong>.</span></div>
<div style="border: 0px; font-stretch: inherit; font-variant-numeric: inherit; line-height: inherit; margin-bottom: 20px; padding: 0px; vertical-align: baseline;">
<span style="font-size: large;">Actualmente estos datos están siendo revisados por la EMA, la <strong style="border: 0px; font-family: inherit; font-stretch: inherit; font-style: inherit; font-variant: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;">Agencia Europea del Medicamento</strong>, la entidad responsable de la autorización de fármacos en Europa. <strong style="border: 0px; font-family: inherit; font-stretch: inherit; font-style: inherit; font-variant: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;">Se espera una decisión este mismo año</strong>.</span></div>
<div style="border: 0px; font-stretch: inherit; font-variant-numeric: inherit; line-height: inherit; margin-bottom: 20px; padding: 0px; vertical-align: baseline;">
<span style="font-size: large;">En EEUU la decisión ha sido tomada antes porque el ocrelizumab recibió estatus de prioridad en la revisión, lo que acelera el proceso de aprobación. La EMA carece de este sistema de prioridad en las revisiones.</span></div>
<div style="border: 0px; font-stretch: inherit; font-variant-numeric: inherit; line-height: inherit; margin-bottom: 20px; padding: 0px; vertical-align: baseline;">
<span style="font-size: large;">– Fuente: Federación Internacional de Esclerosis Múltiple (MSIF). <a href="https://www.msif.org/news/2017/03/29/first-treatment-licensed-for-primary-progressive-ms-in-the-us/#sthash.PjtbB20V.dpuf" style="border: 0px; color: #505050; font-family: inherit; font-stretch: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; line-height: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none; vertical-align: baseline;">https://www.msif.org/news/2017/03/29/first-treatment-licensed-for-primary-progressive-ms-in-the-us/#sthash.PjtbB20V.dpuf</a></span></div>
</div>
</div>
Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-51298550791167145122017-03-30T13:52:00.003+02:002017-03-30T13:52:32.761+02:00<div style="background-color: white; border: 0px; color: #323232; font-family: Arial, Helvetica, Garuda, sans-serif; font-size: 13px; font-stretch: inherit; font-variant-numeric: inherit; line-height: inherit; margin-bottom: 20px; padding: 0px; text-align: justify; vertical-align: baseline;">
La Administración de Alimentos y Medicamentos de EEUU (FDA, por sus siglas en inglés) <strong style="border: 0px; font-family: inherit; font-stretch: inherit; font-style: inherit; font-variant: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;">ha aprobado el ocrelizumab como tratamiento tanto para la EM recurrente como para la primaria progresiva</strong>, convirtiéndose por tanto en el primer tratamiento autorizado para pacientes de EM primaria progresiva.</div>
<div style="background-color: white; border: 0px; color: #323232; font-family: Arial, Helvetica, Garuda, sans-serif; font-size: 13px; font-stretch: inherit; font-variant-numeric: inherit; line-height: inherit; margin-bottom: 20px; padding: 0px; text-align: justify; vertical-align: baseline;">
En los últimos resultados de sus ensayos, los investigadores encontraron que el ocrelizumab reducía las recaídas, la actividad por IRM y disminuía la progresión en EM remitente-recurrente. Además se encontró que <strong style="border: 0px; font-family: inherit; font-stretch: inherit; font-style: inherit; font-variant: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;">ralentizaba la progresión de la EM primaria progresiva</strong>.</div>
<div style="background-color: white; border: 0px; color: #323232; font-family: Arial, Helvetica, Garuda, sans-serif; font-size: 13px; font-stretch: inherit; font-variant-numeric: inherit; line-height: inherit; margin-bottom: 20px; padding: 0px; text-align: justify; vertical-align: baseline;">
Actualmente estos datos están siendo revisados por la EMA, la <strong style="border: 0px; font-family: inherit; font-stretch: inherit; font-style: inherit; font-variant: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;">Agencia Europea del Medicamento</strong>, la entidad responsable de la autorización de fármacos en Europa. <strong style="border: 0px; font-family: inherit; font-stretch: inherit; font-style: inherit; font-variant: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;">Se espera una decisión este mismo año</strong>.</div>
<div style="background-color: white; border: 0px; color: #323232; font-family: Arial, Helvetica, Garuda, sans-serif; font-size: 13px; font-stretch: inherit; font-variant-numeric: inherit; line-height: inherit; margin-bottom: 20px; padding: 0px; text-align: justify; vertical-align: baseline;">
En EEUU la decisión ha sido tomada antes porque el ocrelizumab recibió estatus de prioridad en la revisión, lo que acelera el proceso de aprobación. La EMA carece de este sistema de prioridad en las revisiones.</div>
<div style="background-color: white; border: 0px; color: #323232; font-family: Arial, Helvetica, Garuda, sans-serif; font-size: 13px; font-stretch: inherit; font-variant-numeric: inherit; line-height: inherit; margin-bottom: 20px; padding: 0px; text-align: justify; vertical-align: baseline;">
– Fuente: Federación Internacional de Esclerosis Múltiple (MSIF). <a href="https://www.msif.org/news/2017/03/29/first-treatment-licensed-for-primary-progressive-ms-in-the-us/#sthash.PjtbB20V.dpuf" style="border: 0px; color: #505050; font-family: inherit; font-stretch: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; line-height: inherit; margin: 0px; outline: none; padding: 0px; vertical-align: baseline;">https://www.msif.org/news/2017/03/29/first-treatment-licensed-for-primary-progressive-ms-in-the-us/#sthash.PjtbB20V.dpuf</a></div>
Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-12082562578062940772017-03-17T22:26:00.001+01:002017-03-17T22:26:51.304+01:00<blockquote class="twitter-tweet" data-lang="es">
<div dir="ltr" lang="es">
El Govern se compromete a subir las pensiones desde el ‘primer momento de la independencia’ <a href="https://twitter.com/LaVanguardia">@lavanguardia</a> <a href="https://t.co/0qu7XduVFK">https://t.co/0qu7XduVFK</a></div>
— Toni Feliu Espada (@tonifeliuespada) <a href="https://twitter.com/tonifeliuespada/status/842841169361014784">17 de marzo de 2017</a></blockquote>
<br />
<script async="" charset="utf-8" src="//platform.twitter.com/widgets.js"></script>Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-35741376212339820462017-03-08T12:22:00.000+01:002017-03-08T12:22:31.851+01:00Fisio<span style="font-size: large;">Hoy toca segunda sesión </span>Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-25443748736774157062017-03-04T22:56:00.001+01:002017-03-04T22:56:40.710+01:00Septiembre <span style="font-size: large;">Tendré que espabilar</span>Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-71116912285275672272017-03-02T11:15:00.000+01:002017-03-02T11:15:11.763+01:00<blockquote class="twitter-tweet" data-lang="es">
<div dir="ltr" lang="es">
Congreso de los Diputados: Equiparar pensión mínima contributiva y de viudedad al salario mínimo -... <a href="https://t.co/0e7QGpxnVP">https://t.co/0e7QGpxnVP</a> vía <a href="https://twitter.com/change_es">@change_es</a></div>
— Toni Feliu Espada (@tonifeliuespada) <a href="https://twitter.com/tonifeliuespada/status/837244440657997825">2 de marzo de 2017</a></blockquote>
<br />
<script async="" charset="utf-8" src="//platform.twitter.com/widgets.js"></script>Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-77334892983498110232017-02-24T15:44:00.000+01:002017-02-24T15:44:08.781+01:00<blockquote class="twitter-tweet" data-lang="es">
<div dir="ltr" lang="es">
Después del robo de 14 sesiones de fisio, volvemos con la primera del semestre</div>
— Toni Feliu Espada (@tonifeliuespada) <a href="https://twitter.com/tonifeliuespada/status/835132979332726784">24 de febrero de 2017</a></blockquote>
<br />
<script async="" charset="utf-8" src="//platform.twitter.com/widgets.js"></script>Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-54646832889113852602017-02-05T16:53:00.001+01:002017-02-05T16:53:04.265+01:00Robotic support brings freedom to paraplegics - Tek RMD<iframe allowfullscreen="" frameborder="0" height="270" src="https://www.youtube.com/embed/_gb5poTdUMg" width="480"></iframe>Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-8465074803924648792016-12-31T11:51:00.001+01:002016-12-31T11:51:50.780+01:00<blockquote class="twitter-tweet" data-lang="es"><p lang="es" dir="ltr">Este nuevo año te reto a cumplir un nuevo propòsito, te reto a ser tu mismo</p>— Mi Abuela Sabia (@miabuelasabia) <a href="https://twitter.com/miabuelasabia/status/815145729442410496">31 de diciembre de 2016</a></blockquote>
<script async src="//platform.twitter.com/widgets.js" charset="utf-8"></script>Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-60635757656316465482016-12-18T17:14:00.002+01:002016-12-18T17:14:43.777+01:00Cruz y raya<span style="background-color: #fcfcff; color: #141414; font-family: Verdana, Arial, Tahoma, Calibri, Geneva, sans-serif;"><span style="font-size: large;">Es una expresión que se suele usar cuando alguien te ha jugado una mala pasada y quieres expresar que desde ese momento vuestra relación ha acabado. </span></span>Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-59704785932041963532016-12-14T19:41:00.003+01:002016-12-14T19:41:40.987+01:00<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjwPrghjILdlaGK1m4SweW38rYxWlF5dG6cdfK8DFtZ9ueKPlSZU7RIBsafcMT_VyoObn6ukEUW4QsoXKCX9q3YvFAQBHp_2qFWzVx6dJYj9q_KR0dDbmNWRL0lD8pCR5cugQ0EKf6tBBW_/s1600/Catalunya-que-mes-del-Madrid_1531056942_27469803_1500x1072.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="456" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjwPrghjILdlaGK1m4SweW38rYxWlF5dG6cdfK8DFtZ9ueKPlSZU7RIBsafcMT_VyoObn6ukEUW4QsoXKCX9q3YvFAQBHp_2qFWzVx6dJYj9q_KR0dDbmNWRL0lD8pCR5cugQ0EKf6tBBW_/s640/Catalunya-que-mes-del-Madrid_1531056942_27469803_1500x1072.jpg" width="640" /></a></div>
<br />Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-518852688670646132016-08-30T16:39:00.001+02:002016-08-30T16:39:57.950+02:00<blockquote class="twitter-tweet" data-lang="es"><p lang="es" dir="ltr">4 putos euros ha subido mi pensión en 3 años. Ya sabes Mariano donde puedes ir</p>— Toni Feliu Espada (@tonifeliuespada) <a href="https://twitter.com/tonifeliuespada/status/770629682333151232">30 de agosto de 2016</a></blockquote>
<script async src="//platform.twitter.com/widgets.js" charset="utf-8"></script>Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-58541914673964193902016-08-23T12:34:00.002+02:002016-08-23T12:34:50.164+02:00BoniatosVuelve la energía a mi cuerpoToni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-67226530117560136112016-07-03T12:01:00.000+02:002016-07-03T12:01:04.272+02:00<blockquote class="twitter-tweet" data-lang="es">
<div dir="ltr" lang="und">
Dimetiltriptamina<a href="https://t.co/au9Hz8JxBU">https://t.co/au9Hz8JxBU</a></div>
— Toni Feliu Espada (@tonifeliuespada) <a href="https://twitter.com/tonifeliuespada/status/749543103791501312">3 de julio de 2016</a></blockquote>
<br />
<script async="" charset="utf-8" src="//platform.twitter.com/widgets.js"></script>Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-61497423110688051002016-05-29T12:14:00.000+02:002016-05-29T12:14:21.051+02:00Ahora es el momento peor<span style="font-size: large;">Creo que ya poco da más de si el tema de recuperar movilidad. Ya solo mantengo entre el 5-10% de ella.</span><br />
<span style="font-size: large;"><br /></span>
<span style="font-size: large;">¡¡¡¡A JODERSE Toni!!!!</span>Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-46967757841386878862016-05-06T12:59:00.000+02:002016-05-06T12:59:31.311+02:00Cinta fisiológicaHace días que tengo fuertes dolores musculares en glúteos y lumbares. Como lo clásico no funciona, estoy probando la cinta.<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh7_AmrSjWAR2-XYoybuUqRzIgEogzgrVi_S78X6S9QK7l5ZwmmZekzfs6oKL3BjRaMQ40KfPNyjaqzTbOIbpA8oBt56xSi_uavOJSylGeRGthxkcfccu2pv6CZZ43VNUTT-vSOypfE_JTc/s1600/Picture+1.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="225" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh7_AmrSjWAR2-XYoybuUqRzIgEogzgrVi_S78X6S9QK7l5ZwmmZekzfs6oKL3BjRaMQ40KfPNyjaqzTbOIbpA8oBt56xSi_uavOJSylGeRGthxkcfccu2pv6CZZ43VNUTT-vSOypfE_JTc/s400/Picture+1.jpg" width="400" /></a></div>
<br />Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-69168798589734996682016-04-15T09:31:00.002+02:002016-04-15T09:31:25.698+02:00Vídeo censurado<span style="font-size: large;"><a href="http://www.formulatv.com/noticias/55103/tv3-constitucion-quemada-ardiendo-cubo-empar-moliner/" target="_blank">AQUÍ </a>podéis ver el vídeo censurado de la entrada anterior.</span>Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-26070022899920978412016-04-12T14:28:00.001+02:002016-04-12T14:28:30.863+02:00<iframe width="560" height="315" src="https://www.youtube.com/embed/OTI5yZTt1TQ" frameborder="0" allowfullscreen></iframe>Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-7779009510899675222016-04-03T19:27:00.002+02:002016-04-03T19:27:55.293+02:00Cuatro semanas<span style="font-size: large;">¿Apostáis que dentro de ese espacio de tiempo me hospitalizan?</span>Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0tag:blogger.com,1999:blog-1996070858665183584.post-67422492661086823622016-03-23T10:22:00.004+01:002016-03-23T10:22:39.572+01:00Puerba<span style="font-size: large;">aKKMONizxNRccx3ocGpkbY47GHcAZH5CqXHrJMnR3rOZQ6M4aYytrn3tq1jqsJaIJZeymkkDIlVZ5Z3yyOxFfGT8OoodnvC53aiQ4UlqEofe8DlHhlk/Gr4Rl/QUBds2jsi/53bdZmZIDapF972tlVXUkHKxWQDDw0VdwxvfQHo</span>Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com2tag:blogger.com,1999:blog-1996070858665183584.post-27993752211332419712016-03-04T09:53:00.001+01:002016-03-04T09:53:17.130+01:00Me jode<span style="font-size: large;">Me jode: el tiempo pasa muy rápido pero el mío no se acaba.</span>Toni Feliuhttp://www.blogger.com/profile/00731325593695744341noreply@blogger.com0